Article
Topical application of a vitamin D analogue exacerbates atopic dermatitis and induces the atopic dermatitis-like phenotype in Stat6VT mice.
Pediatric dermatology - 1 Jan 2000
Turner Matthew J, Dasilva-Arnold Sonia C, Yi Qiaofang, Mehrotra Purvi, Kaplan Mark H, Travers Jeffrey B
Abstract excerpt
Calcipotriene is a topical vitamin D3 analogue approved for the treatment of plaque and scalp psoriasis. We report the case of a 2-year-old boy whose atopic dermatitis (AD) flared in response to application of calcipotriene 0.005% cream and solution for a mistaken diagnosis of plaque and scalp psoriasis. We investigated whether the patient's eruption was secondary to an allergic contact dermatitis. In the Stat6VT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
